Gaya APA

SUTIONO, A, B. et al (2013). Akt-the mammalian target of rapamycin (mTOR) pathway inhibition increases cervical cancer cell chemosensitivity to active form of irinotecan (SN-38) . Bandung: Fak. Kedokteran UNPAD.

Gaya MLA

SUTIONO, Agung, Budi. et al. "Akt-the mammalian target of rapamycin (mTOR) pathway inhibition increases cervical cancer cell chemosensitivity to active form of irinotecan (SN-38)". Bandung: Fak. Kedokteran UNPAD, 2013. Artikel.